CLDX - Celldex Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CLDX is currently covered by 4 analysts with an average price target of $88.17. This is a potential upside of $63.21 (253.25%) from yesterday's end of day stock price of $24.96.

Celldex Therapeutics's activity chart (see below) currently has 64 price targets and 86 ratings on display. The stock rating distribution of CLDX is 91.18% BUY and 8.82% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.79% with an average time for these price targets to be met of 69.36 days.

Highest price target for CLDX is $67, Lowest price target is $38, average price target is $59.25.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 20-Aug-2025. First documented stock forecast 19-Dec-2008.

Currently out of the existing stock ratings of CLDX, 31 are a BUY (91.18%), 3 are a HOLD (8.82%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$42

$19.13 (83.65%)

$50

21 days ago
(20-Aug-2025)

6/33 (18.18%)

$21.11 (101.05%)

256

Buy

$38

$15.13 (66.16%)

$37

21 days ago
(20-Aug-2025)

4/5 (80%)

$17.11 (81.91%)

165

Buy

$67

$44.13 (192.96%)

$67

7 months 12 days ago
(29-Jan-2025)

4/18 (22.22%)

$41.49 (162.64%)

62

Buy

$90

$67.13 (293.53%)

$72

1 years 6 months 14 days ago
(27-Feb-2024)

0/4 (0%)

$38.96 (76.33%)

Buy

$68

$45.13 (197.33%)

$70

2 years 30 days ago
(11-Aug-2023)

0/3 (0%)

$37.77 (124.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLDX (Celldex Therapeutics) average time for price targets to be met?

On average it took 69.36 days on average for the stock forecasts to be realized with a an average price target met ratio 20.79

Which analyst has the current highest performing score on CLDX (Celldex Therapeutics) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on CLDX (Celldex Therapeutics)?

Biren Amin works at PIPER SANDLER and has 5 price targets and 6 ratings on CLDX

Which analyst is the currently most bullish on CLDX (Celldex Therapeutics)?

Jonathan Aschoff with highest potential upside - $437.48

Which analyst is the currently most reserved on CLDX (Celldex Therapeutics)?

Mara Goldstein with lowest potential downside - -$19.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?